Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19167276 | 1.00 | ALK (0.33) | ALKPDK2 | |
| SCHEMBL21094704 | 0.99 | ALK (0.34) | ALKPDK2 | |
| SCHEMBL21559059 | 0.98 | ALK (0.33) | ALKPDK2 | |
| SCHEMBL17816868 | 0.97 | ALK (0.33) | ALKPDK2 | |
| SCHEMBL19168734 | 0.96 | ALK (0.32) | ALK | |
| SCHEMBL19166163 | 0.96 | ALK (0.32) | ALK | |
| SCHEMBL19394682 | 0.95 | ALK (0.33) | ALK | |
| SCHEMBL25563028 | 0.95 | ALK (0.32) | ALKPDK2 | |
| SCHEMBL25145818 | 0.94 | ALK (0.33) | ALKPDK2 | |
| SCHEMBL21095300 | 0.94 | ALK (0.31) | ALKPDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10424744-B2 | Compound and organic electronic device comprising the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2019-09-24 | — | — | US | disclosed |
| US-20170213971-A1 | Novel compound and organic electronic device comprising the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2017-07-27 | — | — | US | disclosed |
| US-20170213971-A1 | Novel compound and organic electronic device comprising the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2017-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10424744-B2 | Compound and organic electronic device comprising the same | CHRM1, CHRM2, ESR1 | ALK 596/4885PDK2 2514/4885 |
| US-20170213971-A1 | Novel compound and organic electronic device comprising the same | CHRM1, CHRM2, ESR1 | ALK 657/4885PDK2 2806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.